SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 151 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $230 | +46.5% | 4,673 | +8.3% | 0.00% | 0.0% |
Q4 2023 | $157 | +11.3% | 4,315 | -20.1% | 0.00% | -50.0% |
Q4 2022 | $141 | -99.9% | 5,403 | -26.3% | 0.00% | 0.0% |
Q2 2022 | $181,000 | -85.9% | 7,335 | -67.8% | 0.00% | -77.8% |
Q1 2022 | $1,287,000 | -37.6% | 22,810 | -31.5% | 0.01% | -18.2% |
Q4 2021 | $2,063,000 | +54.1% | 33,287 | +57.7% | 0.01% | +83.3% |
Q3 2021 | $1,339,000 | -15.9% | 21,108 | +9.2% | 0.01% | -14.3% |
Q2 2021 | $1,593,000 | +28.4% | 19,326 | +14.5% | 0.01% | +16.7% |
Q1 2021 | $1,241,000 | -25.8% | 16,875 | -26.9% | 0.01% | -33.3% |
Q4 2020 | $1,673,000 | -15.0% | 23,073 | -44.1% | 0.01% | -30.8% |
Q3 2020 | $1,969,000 | +303.5% | 41,304 | +255.7% | 0.01% | +225.0% |
Q2 2020 | $488,000 | +269.7% | 11,611 | +138.0% | 0.00% | +300.0% |
Q1 2020 | $132,000 | – | 4,878 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $429,009,000 | 24.30% |
Consonance Capital Management LP | 1,201,399 | $88,387,000 | 9.42% |
Boxer Capital, LLC | 2,075,905 | $152,724,000 | 5.18% |
Perceptive Advisors | 4,849,912 | $356,808,000 | 4.51% |
Orbimed Advisors | 6,186,307 | $455,127,000 | 4.26% |
Samsara BioCapital, LLC | 169,852 | $12,496,000 | 2.30% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,262,075 | $92,851,000 | 1.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $41,094,000 | 0.86% |
SPHERA FUNDS MANAGEMENT LTD. | 137,672 | $10,129,000 | 0.78% |
Affinity Asset Advisors, LLC | 27,000 | $1,986,000 | 0.67% |